BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12802798)

  • 1. Current status of oxaliplatin in colorectal cancer.
    O'Dwyer PJ; Johnson SW
    Semin Oncol; 2003 Jun; 30(3 Suppl 6):78-87. PubMed ID: 12802798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxaliplatin: a novel platinum analog with activity in colorectal cancer.
    Berg D
    Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin: a review of preclinical and clinical studies.
    Raymond E; Chaney SG; Taamma A; Cvitkovic E
    Ann Oncol; 1998 Oct; 9(10):1053-71. PubMed ID: 9834817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer.
    Grivicich I; Mans DR; Peters GJ; Schwartsmann G
    Braz J Med Biol Res; 2001 Sep; 34(9):1087-103. PubMed ID: 11514832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin (L-OHP): a new reality in colorectal cancer.
    Bleiberg H
    Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):1-3. PubMed ID: 9647611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxaliplatin: a new therapeutic option in colorectal cancer.
    Cvitkovic E; Bekradda M
    Semin Oncol; 1999 Dec; 26(6):647-62. PubMed ID: 10606258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxaliplatin: a new agent for colorectal cancer.
    Pelley RJ
    Curr Oncol Rep; 2001 Mar; 3(2):147-55. PubMed ID: 11177747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer.
    Simpson D; Dunn C; Curran M; Goa KL
    Drugs; 2003; 63(19):2127-56. PubMed ID: 12962525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irinotecan plus oxaliplatin: a promising combination for advanced colorectal cancer.
    Wasserman E; Sutherland W; Cvitkovic E
    Clin Colorectal Cancer; 2001 Nov; 1(3):149-53. PubMed ID: 12450427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating oxaliplatin into the management of colorectal cancer.
    Schmoll HJ; Cassidy J
    Oncologist; 2001; 6 Suppl 4():24-8. PubMed ID: 11585971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of oxaliplatin monotherapy: phase II trials in advanced colorectal cancer.
    Becouarn Y; Rougier P
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):23-31. PubMed ID: 9609105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxaliplatin in colorectal cancer: current studies.
    Goldberg R
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):42-7. PubMed ID: 11204663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oxaliplatin: the first DACH platinum in clinical practice].
    SouliƩ P; Raymond E; Brienza S; Cvitkovic E
    Bull Cancer; 1997 Jun; 84(6):665-73. PubMed ID: 9295871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.
    Culy CR; Clemett D; Wiseman LR
    Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oxaliplatin: a first DACH-platinum in oncology].
    Laadem A; Cvitkovic E
    Bull Cancer; 2001 Aug; 88 Spec No():S9-13. PubMed ID: 11567908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer.
    Khayat D; Gil-Delgado M; Antoine EC; Nizri D; Bastian G
    Oncology (Williston Park); 2001 Apr; 15(4):415-29; discussion 429-30, 433-4. PubMed ID: 11346931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunities for newer agents in combination with oxaliplatin.
    Hochster HS
    Semin Oncol; 2003 Aug; 30(4 Suppl 15):62-7. PubMed ID: 14523797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent progress of chemotherapy for colorectal cancer].
    Ishiguro A; Shitara K; Munakata M; Saitoh S; Sakata Y
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2017-23. PubMed ID: 16352922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
    Nukatsuka M; Nakagawa F; Takechi T
    Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxaliplatin in colorectal cancer].
    Boni C; Banzi M
    Tumori; 2001; 87(1 Suppl 1):S51-2. PubMed ID: 11300025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.